| DESCRIPTION OF ENHANCEMENTS |
This patch contains the following enhancements:
2. Within the Drug Enter/Edit [PSS DRUG ENTER/EDIT] option, a
significant enhancement to the Mark/Unmark for Lab Monitor or
Clozapine procedure was made.
A. When updating Clozapine information, the user will have a choice
to add, edit, or delete Clozapine Lab Test(s) for the selected
drug.
B. When updating Clozapine information, the user will have to add
identification of two laboratory tests, WBC and Absolute
Neutrophil Count (ANC).
C. In the post-installation process, we added code to move data from
the CLOZ node to the CLOZ2 node in the DRUG file (#50). (This is
3. In the DRUG file (#50), we expanded the field length of the WARNING
LABEL field (#8) to 25 characters to allow longer names.
4. The routine PSSPOIDT was updated to properly delete data from the
INACTIVE DATE field (#100) in the DRUG file (#50) when a drug is
reactivated.
1. In the pre-installation process, we added code to:
A. Delete the DRUG GROUP/INTERACTION field (#7) from the DRUG file
(#50). This field has been marked for deletion.
B. Delete the "I" node in the DRUG file (#50) if it does not contain
data.
|
